GNBT News and Press, Generex Biotechnology From 11/13/19

MIRAMAR, Fla., Nov. 13, 2019 (GLOBE NEWSWIRE) -- Generex Biotechnology Corporation ( www.generex.com ) (OTCQB:GNBT) today announced that it will hold an investor conference call on Friday November 29, 2019 at 9:30 am. Joseph Moscato, Generex President & Chief Executive Officer stated...

MIRAMAR, Fla., Nov. 08, 2019 (GLOBE NEWSWIRE) -- Generex Biotechnology Corporation (OTCQB: GNBT) is pleased to announce that its 10k annual report will be filed Tuesday morning within the time afforded to public companies under the standard filing extension. Generex has received many calls ...

Principal investigator Dr. Jaime Guevara Aguirre, world-renowned expert on growth hormone to conduct the trial of Altsulin ® (Microencapsulated Sertoli Cells) in Laron Syndrome Patients Laron Syndrome (aka Laron-type dwarfism) is a rare pediatric orphan disease eligible for the FDA...

New Dates Established for 1:1 Shareholder stock dividend • Pay Date: November 29, 2019 • Ex-Date: December 2, 2019 • Record Date remains August 30, 2019 MIRAMAR, Fla., Oct. 29, 2019 (GLOBE NEWSWIRE) -- Generex Biotechnology Corporation ( www.generex.com ) ...

MIRAMAR, Fla., Oct. 28, 2019 (GLOBE NEWSWIRE) -- Generex Biotechnology Corporation ( www.generex.com ) (OTCQB:GNBT) ( http://www.otcmarkets.com/stock/GNBT/quote ) today announced the following access information for its investor conference call, to be hosted by President & Chief Executi...

MIRAMAR, Fla., Oct. 25, 2019 (GLOBE NEWSWIRE) -- Generex Biotechnology Corporation ( www.generex.com ) (OTCQB:GNBT) today announced that it will hold an investor conference call on Tuesday October 29, 2019 at 9:30 am. Joseph Moscato, Generex President & Chief Executive Officer stated...

MIRAMAR, Fla., Oct. 18, 2019 (GLOBE NEWSWIRE) -- Generex Biotechnology Corporation (OTCQB:GNBT) is pleased and proud to announce that the company’s Chief Medical and Scientific Officer Dr. Jason Terrell, MD was recently awarded the Shepperd Pathfinder Award for his work in cancer res...

MIRAMAR, Fla., Oct. 15, 2019 (GLOBE NEWSWIRE) -- Generex Biotechnology Corporation ( www.generex.com ) (OTCQB:GNBT) today announced a merger transaction with a public company that is DTC eligible and current with its SEC filings to serve as a vehicle for the quotation of the common stoc...

MIRAMAR, Fla., Oct. 14, 2019 (GLOBE NEWSWIRE) -- Generex Biotechnology Corporation ( www.generex.com ) (OTCQB:GNBT) ( http://www.otcmarkets.com/stock/GNBT/quote ) today announced the following access information for its investor conference call, to be hosted by President & Chief Executi...

Special poster reception on October 13, 2019 , at Caesars Palace, Las Vegas, the official site of the SAWC Meeting Clinical data demonstrate accelerated healing of diabetic neuropathic foot ulcers with Excellagen wound conforming gel matrix MIRAMAR, Fla., Oct. 10, 2019 (GLOBE NEWSWIR...